163 related articles for article (PubMed ID: 26825841)
1. Therapeutic Dilemma: Prognostic Factors and Outcome for Neuroendocrine Tumors of the Cervix.
Abdallah R; Bush SH; Chon HS; Apte SM; Wenham RM; Shahzad MM
Int J Gynecol Cancer; 2016 Mar; 26(3):553-60. PubMed ID: 26825841
[TBL] [Abstract][Full Text] [Related]
2. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
Singh P; Tripcony L; Nicklin J
Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
[TBL] [Abstract][Full Text] [Related]
3. Pathological Risk Factors and Outcomes in Women With Stage IB2 Cervical Cancer Treated With Primary Radical Surgery Versus Chemoradiotherapy.
Bradbury M; Founta C; Taylor W; Kucukmetin A; Naik R; Ang C
Int J Gynecol Cancer; 2015 Oct; 25(8):1476-83. PubMed ID: 26244756
[TBL] [Abstract][Full Text] [Related]
4. Concurrent chemoradiotherapy incorporating high-dose rate brachytherapy for locally advanced cervical carcinoma: survival outcomes, patterns of failure, and prognostic factors.
Teh J; Yap SP; Tham I; Sethi VK; Chua EJ; Yeo R; Ho TH; Tay EH; Chia YN; Soh LT; Khoo-Tan HS
Int J Gynecol Cancer; 2010 Apr; 20(3):428-33. PubMed ID: 20375809
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine carcinoma of the uterine cervix: the role of multimodality therapy in early-stage disease.
McCann GA; Boutsicaris CE; Preston MM; Backes FJ; Eisenhauer EL; Fowler JM; Cohn DE; Copeland LJ; Salani R; O'Malley DM
Gynecol Oncol; 2013 Apr; 129(1):135-9. PubMed ID: 23357610
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.
Werner-Wasik M; Schmid CH; Bornstein L; Ball HG; Smith DM; Madoc-Jones H
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1309-17. PubMed ID: 7635770
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study.
Salvo G; Flores Legarreta A; Ramalingam P; Jhingran A; Bhosale P; Saab R; Gonzales NR; Chisholm GB; Frumovitz M
Int J Gynecol Cancer; 2023 Sep; 33(9):1359-1369. PubMed ID: 37567596
[TBL] [Abstract][Full Text] [Related]
8. Robotic Surgery in Patients With Locally Advanced Cervical Cancer After Neoadjuvant Chemotherapy: Survival Outcomes.
Siesto G; Romano F; Accardi A; Bulletti C; Iedà NP; Vitobello D
Int J Gynecol Cancer; 2016 Mar; 26(3):521-7. PubMed ID: 26825842
[TBL] [Abstract][Full Text] [Related]
9. Liver-directed therapy for neuroendocrine neoplasm hepatic metastasis prolongs survival following progression after initial surgery.
Saxena A; Chua TC; Zhao J; Morris DL
J Surg Oncol; 2012 Mar; 105(4):342-50. PubMed ID: 22006355
[TBL] [Abstract][Full Text] [Related]
10. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study.
Atahan IL; Onal C; Ozyar E; Yiliz F; Selek U; Kose F
Int J Gynecol Cancer; 2007; 17(4):833-42. PubMed ID: 17367320
[TBL] [Abstract][Full Text] [Related]
12. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
[TBL] [Abstract][Full Text] [Related]
13. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence.
Viswanathan AN; Deavers MT; Jhingran A; Ramirez PT; Levenback C; Eifel PJ
Gynecol Oncol; 2004 Apr; 93(1):27-33. PubMed ID: 15047210
[TBL] [Abstract][Full Text] [Related]
14. Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix: a retrospective matched case-control study.
Lee SW; Nam JH; Kim DY; Kim JH; Kim KR; Kim YM; Kim YT
Int J Gynecol Cancer; 2010 Apr; 20(3):411-6. PubMed ID: 20375806
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
[TBL] [Abstract][Full Text] [Related]
16. Patterns of recurrence and survival in neuroendocrine cervical cancer.
Stecklein SR; Jhingran A; Burzawa J; Ramalingam P; Klopp AH; Eifel PJ; Frumovitz M
Gynecol Oncol; 2016 Dec; 143(3):552-557. PubMed ID: 27645621
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Factors of Surgically Treated Early-Stage Small Cell Neuroendocrine Carcinoma of the Cervix.
Yuan L; Jiang H; Lu Y; Guo SW; Liu X
Int J Gynecol Cancer; 2015 Sep; 25(7):1315-21. PubMed ID: 26186071
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Survival in Patients With FIGO Stage IVB Cervical Cancer.
Sasano T; Mabuchi S; Kuroda H; Takahashi R; Kozasa K; Isohashi F; Yoshioka Y; Ogawa K; Kimura T
Int J Gynecol Cancer; 2016 Mar; 26(3):528-33. PubMed ID: 26825839
[TBL] [Abstract][Full Text] [Related]
19. A multi-center retrospective study of neuroendocrine tumors of the uterine cervix: Prognosis according to the new 2018 staging system, comparing outcomes for different chemotherapeutic regimens and histopathological subtypes.
Ishikawa M; Kasamatsu T; Tsuda H; Fukunaga M; Sakamoto A; Kaku T; Kato T; Takahashi K; Ariyoshi K; Suzuki K; Arimoto T; Matsumoto Y; Nakai H; Inoue T; Yokoyama M; Kawabata T; Kodama S; Miyamoto T; Takano M; Yaegashi N
Gynecol Oncol; 2019 Dec; 155(3):444-451. PubMed ID: 31635755
[TBL] [Abstract][Full Text] [Related]
20. Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
Zivanovic O; Leitao MM; Park KJ; Zhao H; Diaz JP; Konner J; Alektiar K; Chi DS; Abu-Rustum NR; Aghajanian C
Gynecol Oncol; 2009 Mar; 112(3):590-3. PubMed ID: 19110302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
